hVIVO plc (LON:HVO – Get Free Report)’s share price traded up 13% on Monday . The stock traded as high as GBX 8 ($0.11) and last traded at GBX 7.80 ($0.10). 6,691,976 shares changed hands during mid-day trading, an increase of 126% from the average session volume of 2,955,294 shares. The stock had previously closed at GBX 6.90 ($0.09).
Analyst Upgrades and Downgrades
Several analysts have weighed in on the stock. Shore Capital dropped their price objective on shares of hVIVO from GBX 35 to GBX 25 and set a “buy” rating for the company in a research note on Tuesday, September 23rd. Peel Hunt reiterated an “add” rating and issued a GBX 21 price objective on shares of hVIVO in a research note on Tuesday, July 29th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of GBX 23.
Check Out Our Latest Research Report on HVO
hVIVO Stock Up 14.0%
hVIVO (LON:HVO – Get Free Report) last issued its earnings results on Tuesday, September 23rd. The company reported GBX (0.29) EPS for the quarter. hVIVO had a net margin of 25.96% and a return on equity of 47.93%. On average, sell-side analysts forecast that hVIVO plc will post 1.5492958 EPS for the current fiscal year.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than hVIVO
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Copper Stocks Ready to Shine in the Next Metal Supercycle
- Expert Stock Trading Psychology Tips
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- What is a support level?
- Could Target’s Week of Discounts Come Full Circle for Investors?
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
